Sandip I. Patel's most recent trade in Akari Therapeutics Plc - ADR was a trade of 247,462 Warrants to purchase American Depositary Shares ("ADRs") done . Disclosure was reported to the exchange on Dec. 16, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Akari Therapeutics PLC (ADR) | Sandip I. Patel | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 16 Dec 2025 | 247,462 | 247,462 | - | - | Warrants to purchase American Depositary Shares ("ADRs") | |
| Akari Therapeutics PLC (ADR) | Sandip I. Patel | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 16 Dec 2025 | 247,462 | 247,462 | - | - | Pre-Funded Warrants to purchase ADRs | |
| Akari Therapeutics PLC (ADR) | Sandip I. Patel | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 16 Dec 2025 | 154,664 | 154,664 | - | - | Pre-Funded Warrants to purchase ADRs | |
| Akari Therapeutics PLC (ADR) | Sandip I. Patel | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 16 Dec 2025 | 154,664 | 154,664 | - | - | Warrants to purchase ADRs | |
| Akari Therapeutics PLC (ADR) | Sandip I. Patel | Director | Grant, award, or other acquisition of securities at price $ 1.12 per share. | 25 Apr 2025 | 44,642 | 496,499 (0%) | 0% | 1.1 | 49,999 | American Depositary Shares representing Ordinary Shares |
| Akari Therapeutics PLC (ADR) | Sandip I. Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2025 | 44,642 | 44,642 | - | - | Series A Warrants (Right to Buy) | |
| Akari Therapeutics PLC (ADR) | Sandip I. Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2025 | 44,642 | 44,642 | - | - | Series B Warrants (Right to Buy) | |
| Akari Therapeutics PLC (ADR) | Sandip I. Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2025 | 225,000 | 225,000 | - | - | Stock Option (Right to Buy) | |
| Akari Therapeutics PLC (ADR) | Sandip I. Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2025 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| Monterey Innovation Acquis... | Sandip I. Patel | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.01 per share. | 09 Mar 2023 | 570,000 | 1,342,500 | - | 0.0 | 3,420 | Common Stock |
| Monterey Innovation Acquis... | Sandip I. Patel | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 09 Mar 2023 | 75,000 | 1,417,500 | - | - | Common Stock |